MSH2 and neoplasm: Sahnane et al. reported that out of 89 gastroenteropancreatic NECs and MANECs, 4 (4.5%) occurred in the duodenum, and one was an MMR-deficient tumor with the deletion of MSH2 and MSH6 immunohistochemically [29].